Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma

Affiliations

• ¹ Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA. Electronic address: nnathwani@coh.org.
• ² Division of Biostatistics, Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, CA; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
• ³ Department of Cancer Biology, City of Hope, Duarte, CA.
• ⁴ Department of Diabetes, Endocrinology and Metabolism, City of Hope, Duarte, CA.
• ⁵ Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.
• ⁶ Department of Clinical Protocol Development, City of Hope, Duarte, CA.
• ⁷ Division of Hematology/Medical Oncology, Northwestern University, Chicago, IL.
• ⁸ Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA; Southern California Permanente Medical Group, Los Angeles, CA.
• ⁹ Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.